title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger - Pyxis Oncology  ( NASDAQ:PYXS ) , Syndax Pharmaceuticals  ( NASDAQ:SNDX ) ",20240610T113000,https://www.benzinga.com/pressreleases/24/06/g39247597/pyxis-oncology-expands-board-of-directors-with-appointment-of-michael-a-metzger,SNDX,0.088309,Neutral,0.074266
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger,20240610T113000,https://www.globenewswire.com/news-release/2024/06/10/2895898/0/en/Pyxis-Oncology-Expands-Board-of-Directors-with-Appointment-of-Michael-A-Metzger.html,SNDX,0.093108,Neutral,0.078209
Why Is Incyte  ( INCY )  Up 2.1% Since Last Earnings Report?,20241128T163138,https://www.zacks.com/stock/news/2376668/why-is-incyte-incy-up-21-since-last-earnings-report,SNDX,0.03804,Neutral,0.009861
"INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales",20241029T144700,https://www.zacks.com/stock/news/2359805/incy-q3-earnings-miss-estimates-revenues-beat-on-higher-product-sales,SNDX,0.044801,Neutral,0.009972
